In vivo, APR-246 has shown impressive cytotoxic and apoptotic effects in murine cancer models of such as mutant p53 small cell lung carcinoma [97], multiple myeloma [98] and breast cancer [99]. This evidence concerns the gene TP53 and small cell lung carcinoma.